key: cord-0809168-jd9u5yq7
authors: Robinson, Carolyn-Ann; Kleer, Mariel; Mulloy, Rory P.; Castle, Elizabeth L.; Boudreau, Bre Q.; Corcoran, Jennifer A.
title: Human coronaviruses disassemble processing bodies
date: 2020-11-09
journal: bioRxiv
DOI: 10.1101/2020.11.08.372995
sha: 183792dabf2ba253315f0d43bf84c6aff6996406
doc_id: 809168
cord_uid: jd9u5yq7

The Coronaviridae are a family of viruses with large RNA genomes. Seven coronaviruses (CoVs) have been shown to infect humans, including the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease of 2019 (COVID-19). The host response to CoV infection is complex and regulated, in part, by intracellular antiviral signaling pathways triggered in the first cells that are infected. Emerging evidence suggests that CoVs hijack these antiviral responses to reshape the production of interferons and proinflammatory cytokines. Processing bodies (PBs) are membraneless ribonucleoprotein granules that mediate decay or translational suppression of cellular mRNAs; this is particularly relevant for proinflammatory cytokine mRNA which normally reside in PBs and are repressed. Emerging evidence also suggests that PBs or their components play important direct-acting antiviral roles, providing a compelling reason for their frequent disassembly by many viruses. No information is known about how human CoVs impact PBs. Here, we provide data to show that infection with the human CoV, OC43, causes PB disassembly. Moreover, we show that several SARS-CoV-2 gene products also mediate PB loss and virus-induced PB loss correlates with elevated levels of proinflammatory cytokine mRNAs that would normally be repressed in PBs. Finally, we demonstrate that stimulating PB formation prior to OC43 infection restricts viral replication. These data suggest that SARS-CoV-2 and other CoVs disassemble PBs during infection to support viral replication and evade innate immune responses. As an unintended side effect, the disassembly of PBs enhances translation of proinflammatory cytokine mRNAs which normally reside in PBs, thereby reshaping the subsequent immune response.

PBs are ubiquitous, biomolecular condensates that form via liquid-liquid phase separation of 26 proteins with regions of intrinsic disorder, and from RNA-protein and RNA-RNA interactions 27

(1-5). PBs are comprised of the enzymes required for mRNA turnover, including those needed 28 for decapping (Dcp2 and co-factors Dcp1a and Edc4/Hedls) and decay of the RNA body (5'-3' 29 exonuclease Xrn1 and RNA helicase Rck/DDX6) and some components of the RNA-induced 30 silencing complex (2,6). The RNA found in PBs consists of one third of all coding transcripts 31 which are poorly translated and non-coding RNAs (2,4,7,8). mRNA transcripts, consisting 32 predominantly of grouped regulatory mRNAs with related biological functions, are delivered to 33

PBs by RNA-binding proteins (RBPs) (2,4). One such group bear destabilizing AU-rich elements 34

(AREs) in their 3'-untranslated regions (3'-UTRs) and encode potent regulatory molecules like 35 growth factors, pro-inflammatory cytokines, and angiogenic factors, making their turnover 36 and/or suppression in PBs fundamental to our physiology (9-11). We and others showed that the 37 presence of visible PBs correlates with increased turnover/suppression of ARE-mRNAs (11-15). 38

Conversely, when PBs are lost, constitutive ARE-mRNA suppression is reversed. This provides 39 cells with a means to rapidly respond to stimuli that disassemble PBs to produce 40 proinflammatory cytokines, making PB disassembly an important yet underappreciated 41 regulatory mechanism that tunes the production of potent proinflammatory cytokines that contain 42

AREs, molecules like IL-6, IL-8, IL-1β, and TNF (9). 43 44 PBs are constitutive, dynamic ribonucleoprotein (RNP) granules that change in size and number 45 in response to different stimuli. We and others have shown that stressors that activate the 46 p38/MK2 MAP kinase pathway, as well as many virus infections elicit PB disassembly 47 (12,13,15-18). Disassembly can occur by a direct interaction between a viral protein(s) and a PB 48 component that is subsequently re-localized to viral replication and transcription compartments 49 (vRTCs) (19-21) or cleaved by viral proteases (21-23). Viruses can also cause PB disassembly 50 indirectly by activating p38/MK2 signaling (12,13). Despite numerous reports of viral gene 51 products that trigger PB disassembly, corresponding reports of viral gene products that stimulate 52 PB formation are rare, which suggests that PBs possess direct antiviral function and their 53 disassembly may favour viral replication in ways that we fail to grasp (24 ORF9c) by immunoblotting whole cell lysates harvested from parallel transfections (Fig 1C) . We 130 were unable to detect nsp4 and ORF10 by immunoblotting; however, we did visualize these 131 proteins in immunostained samples. Consistent with previous work (57), we were unable to 132 detect nsp6 by immunoblotting or by immunostaining, despite our observation that these cells 133 appear to have less DDX6-positive puncta than our controls (Fig 1B, C) . 134 135 A screen of SARS-CoV-2 genes reveals enhancers of an ARE-containing luciferase reporter 136

We performed a secondary reporter screen to identify SARS-CoV-2 proteins that enhanced the 137 activity of a firefly luciferase (FLuc) reporter containing an ARE sequence in its 3' UTR, 138 rendering the mRNA sensitive to constitutive turnover or translational suppression in PBs (59). 139

For this reason, control samples display extremely low levels of FLuc luminescence relative to a 140 non-ARE renilla luciferase (RLuc) transfection control, that reflects the turnover or suppression 141 of the FLuc mRNA (Fig 2A) . When reporter constructs are co-transfected with the positive 142 control protein, KapB, which we have previously shown to cause PB disassembly and elevate the 143 FLuc ARE-mRNA reporter (13,59), the relative luminescence is enhanced ~50-fold ( Fig 2B) . 144

After co-transfection with the SARS-CoV-2 gene library, we identified three SARS-CoV-2 145 proteins that significantly elevated relative luminescence as well as or better than KapB: nsp1 146 (150-fold), nsp14 (80-fold), and ORF7b (40-fold), and two others that elevated luminescence 10-147 20-fold: nsp13 and ORF6 ( Fig 2B) . Of these ARE-mRNA regulating SARS-CoV-2 gene 148 products, two overlap with those we showed to cause PB loss, nsp1 and ORF7b (Fig 1) . 149

Validation of SARS-CoV-2 genes that cause PB loss in primary endothelial cells 151

Endothelial cells (ECs) have emerged as playing a significant role in severe COVID, they are 152 also sources for many of the cytokines elevated in severe disease and are infected by SARS-153

CoV-2 (48,60-63). We validated top hits from our PB and ARE-containing reporter screen in 154 human umbilical vein endothelial cells (HUVECs) that were transduced with recombinant 155 lentiviruses expressing N, nsp14 or a vector control. Transduced cells were selected and stained 156 for the endogenous PB marker protein DDX6 and for the Strep-tag II on each of SARS-CoV-2 157

constructs. Compared to the control, we observed PB loss in N-expressing cells and a decrease in 158 PB numbers in the nsp14-transduced cell population (Fig 3) . We also observed that in some 159 cells, nsp14 staining, although usually difficult to detect, overlapped with DDX6-positive puncta 160 in nsp14-transfected HeLa cells (Fig 3B, C) . The significance of this observation is unclear and 161

we are investigating it further. 162 163

To understand if PBs were lost during infection with human coronaviruses, we established an 165 infection model for the human CoV, OC43, in HUVECs. We tested the ability of OC43 to enter 166 and replicate in these primary cells and confirmed that HUVECs are permissive to OC43 (Fig  167   4A) . We then performed a time-course experiment wherein OC43-infected HUVECs were fixed 168 at various times post infection and stained for DDX6 (PBs) and the viral nucleocapsid (N) 169 protein to denote infected cells. We observed that PBs were lost after infection with OC43 but 170 not lost over the time course of the experiment in our mock-infected control cells (Fig 4A-B) . 171

These results showed that PB counts were significantly diminished at 12 and 24 hpi (Fig 4A-B) . 172

To determine if the reduced PB counts correlated with changes to cytokine mRNA levels, we 173 harvested total RNA from OC43-infected cells at 24 hpi and performed RT-qPCR for two ARE-174 containing cytokine transcripts, IL-6 and IL-8 ( Fig 4C) . Consistent with the observed reduction 175

in PBs, the steady-state levels of IL-6 and IL-8 mRNA both increased ~20-fold compared to 176 uninfected cells (Fig 4C) . We also observed, in some infected cells, DDX6-positive puncta 177 reappeared at 24 hpi, but these puncta did not resemble PBs in terms of their size or shape but 178 were larger, non-spherical aggregates. It is unclear at this time if these DDX6-positive 179 aggregates represent vRTCs or stress granules, another RNP granule that viruses manipulate 180 (25,26). Further experiments will determine the nature of these aggregates. 181

Since SARS-CoV-2 encodes six proteins that induce PB loss and infection with OC43 184 recapitulates this loss, we hypothesized that PBs may be able to restrict coronavirus infection. To 185 test this, we used lentiviruses to deliver the fluorescently-labeled PB protein, GFP-Dcp1a, or a 186 control GFP protein to HUVECs prior to infecting with OC43. At various times post infection, 187 cells were fixed and stained for the viral nucleocapsid (N) protein ( Fig 5A) . Although OC43 was 188 able to express N in GFP-positive control cells, we observed viral N gene expression was 189 restricted in cells that expressed GFP-Dcp1a ( Fig 5A) . The restriction was most pronounced at 190 6hpi, when we observed only ~20% of GFP-Dcp1a-positive cells were visibly infected, 191 compared to the GFP-only controls (Fig 5B) . At later infection times, more N gene expression 192 was observed in cells also expressing GFP-Dcp1a, suggesting that OC43 infection was able to 193 overcome the restriction imposed by GFP-Dcp1a ( Fig 5B) . Next, we examined if an increased 194 dose of the GFP-Dcp1a lentivirus, that should elicit the formation of more PBs, would increase 195 the restrictive phenotype ( Fig 5C) . HUVECs were transduced with 5-fold more GFP-Dcp1a 196 lentivirus than in Fig 5B, infected with OC43, and the infected cell supernatant was collected at 197 24hpi ( Fig 5C) . The amount of OC43 infectious particles produced in each condition was 198 determined using a TCID50 assay (64). Infectious OC43 particles were produced from control 199 cell populations transduced with the GFP virus and there was no significant difference in viral 200 particles produced after transduction with a lower dose of GFP-Dcp1a lentivirus ( Fig 5C) . 201

However, the addition of 5-fold more GFP-Dcp1a lentivirus prior to OC43 infection restricted 202 viral replication and no infectious OC43 particles were detected in the 24hpi-supernatant taken 203 from these cells ( Fig 5C) . Taken together, these data show that PB fortification prior to OC43 In this manuscript, we present data to show that the human CoV, OC43, causes PB loss during 210 infection. The loss of PBs correlates with elevated steady-state levels of two PB-regulated 211 cytokines, IL-6 and IL-8. Using a gene library, we also identify six candidate gene products 212 encoded by SARS-CoV-2 that are capable of inducing PB loss and three candidate gene products 213 that stabilize an ARE-containing luciferase reporter. Moreover, we present evidence that prior 214 fortification of PB granules using overexpression of the PB protein, GFP-Dcp1a, restricts the 215 infectious cycle of OC43, delaying viral nucleocapsid protein production and preventing 216 infectious progeny production. These data support our model that PBs are antiviral granules 217 designed to protect cells from viral invaders. 218

Multiple SARS-CoV-2 gene products highlight the diversity of approaches used by one virus to 220

We screened 27 SARS-CoV-2 gene products by transfection in HeLa cells (57) and identified six 222 candidates that reduce PB numbers including the viral nucleocapsid protein (N), the viral host 223 shutoff factor (nsp1), non-structural proteins nsp6 and nsp11, and accessory proteins ORF7b and 224 ORF3b (Fig 1) . The most significant of these candidates was the N protein, which we also 225 showed caused endogenous PB loss in primary ECs (Fig 3) . N is a multifunctional RNA-binding 226 protein (RBP) that coats the viral genome and induces phase separation to promote viral particle 227 assembly (37,65-68). N possesses several non-specific RNA-binding regions and is 228 phosphorylated in its central serine-arginine (SR-rich) domain (68,69). SARS-CoV-2 N also 229 contains three putative NLS sequences (70). One possible reason for PB loss may be the 230 indiscriminate RNA binding of N protein which acts as sponge for RNA, pulling it out of 231 cytoplasm, reducing the RNA-protein interactions required for phase separation of PBs (3). We 232 are currently engaged in site-directed and truncation mutagenesis studies to determine the precise 233 region(s) of N that are essential for its effect on PBs (71). Another PB-regulating SARS-CoV-2 234 protein we discovered is the bifunctional enzyme, nsp14, which possesses an N-terminal 235 exonuclease domain (ExoN) required for proofreading of the CoV polymerase complex and a C-236 terminal N-methyltransferase (MTase) domain that contributes to viral RNA capping (37,72). 237

Nsp14 caused PB loss in our EC validation studies yet it did not cause PB loss in HeLa cells (Fig  238   1, 3) . Though we are unclear of the precise reason for these discrepant results, one consideration 239 is that GFP-Dcp1a expression in HeLa cells makes PBs more stable and their disassembly more 240 difficult. It was also quite difficult to detect the expression of nsp14 in HeLa cells after their 241 transfection, although nsp14 was detected by immunoblotting; therefore, PBs were counted in all 242 cells, and the results were not specific for cells that expressed nsp14 (Fig 1) . In contrast, in our 243 EC validation studies we selected for transduced cells; thus, all ECs contain nsp14 even if the 244 staining is low (Fig 3) . This may explain the significant PB loss observed in ECs and not in 245

HeLa cells. Finally, we observed that nsp14 occasionally formed small puncta that overlapped 246 with DDX6-positive PBs in both HeLa cells and ECs (Fig 3A, 3C ). There are no previous reports 247 of any other CoV proteins co-localizing to PBs. The significance of this observation remains 248

unclear. We will continue to interrogate nsp14 localization using confocal microscopy and 249 immunoprecipitation assays. Nsp14 was also a significant hit in the luciferase reporter assay ( For this reason, PB-regulated transcripts like the ARE-containing FLuc reporter may be resistant 268 to nsp1-mediated shutoff (Fig 2) . We are currently validating if nsp1 is a PB-regulating viral 269 protein in ECs and will explore its effects on cytokine mRNA levels. In addition, ORF7b and the 270 short ORF3b are intriguing hits because both are accessory proteins that have been reported to 271 either activate the kinase p38 (an inducer of PB disassembly) or antagonize IFN responses 272 (53,80). Not picked up in our screen, the viral 3C-like protease, nsp5, is also of particular interest 273 because porcine CoV nsp5 cleaves Dcp1a, an event that would be predicted to cause PB 274 disassembly (81). Although nsp6 and nsp11 were top hits in our unthresholded PB screen (Fig  275   1) , their expression is either toxic or difficult to detect and we are engaged in developing 276 strategies to minimize these issues and study them further. 277

PBs are antiviral granules that restrict CoV infection 279

We used the human CoV, OC43, to infect ECs and show that virus infection caused significant 280 PB loss at 12 and 24 hpi (Fig 4) . We then fortified PBs using the overexpression of GFP-Dcp1a 281 and showed that PB fortification before infection delayed the visual expression of viral 282 nucleoprotein and restricted the production of infectious viral particles (Fig 5) . However, the 283 precise details of the mechanism of restriction remain unclear. We are engaged in ongoing time 284 course experiments to determine if the restrictive phenotype represents a delay of viral progeny 285 production or a complete block. It is also unclear if the prior GFP-Dcp1a overexpression restricts 286 OC43 replication due to a direct antiviral role of the Dcp1a enzyme itself or its ability to promote 287 the formation of larger PBs (82,83). GFP-Dcp1a overexpression is a common approach used to 288 visualize PBs, and we know these GFP-positive puncta co-stain with endogenous PB proteins 289 (Fig 1) (82) . However, GFP-Dcp1a puncta are larger and may be more stable than endogenous 290

PBs (56,83). Our ongoing work will utilize other molecular tools that regulate PB dynamics to 291 determine if certain PB resident proteins exert antiviral properties independent from the 292 formation of the PB granule itself. We are currently engaged in experiments to overexpress 293 different PB proteins that have roles in RNA decay (Dcp1a, DDX6 RNA helicase, the decapping 294 cofactor hedls/Edc4 or the exonuclease Xrn1) as well as PB proteins that do not directly mediate 295 RNA decay but play an important condensation role for PB granule formation (Lsm14A, 4E-T) 296

(3,4,84). Each of the proposed proteins will affect PBs differently when overexpressed: Dcp1a, 297 hedls/Edc4 and DDX6 increase PB formation, with Dcp1a expression inducing larger granules 298 than the others, Dcp2 has no effect on granule size/number, and Xrn-1 eliminates PBs because it 299 increases mRNA decay (4,83-86). We predict that other GFP-tagged PB proteins that promote 300 molecular condensation of PBs, such as GFP-DDX6, will also restrict OC43 infection. 301

Conversely, we expect that the overexpression of Xrn1 will promote viral infection (as shown by 302 others (34)) because it prevents PB formation, even though it can degrade viral RNA. 303

There is increasing evidence in support of our hypothesis that the antiviral role of PB-localized 305 enzymes is promoted by phase separation of molecules into PBs and that the antiviral function of 306 these molecules is lost when PB granules decondense. This has been previously proposed for 307 decapping complexes, the enzymatic activity of which is increased by phase separation and Although it remains unclear if organization of particular proteins in PBs, or the higher order 329 condensation of many proteins into the PB, regulates its antiviral activity (82,87) , what is clear is 330 that PB disassembly reverses the constitutive decay or translational suppression of cytokine 331 mRNAs that contain AREs that would normally occur there (11-15,88) . These data suggest that 332 when viruses coordinate an attack to cause PB loss, this event relieves the cytokine mRNA 333 suppression and acts as a danger signal that signals the immune system for help. In this way, PB 334 disassembly may be a central component of the cellular innate immune response and part of the 335 sequelae of signals that notify the immune system that a cell is infected. In situations where 336 interferon responses are delayed or defective, as is emerging for SARS-CoV-2 and severe 337 COVID (45-53), PB disassembly may be an important contributing factor to pathogenic cytokine 338 responses. Therefore, in part two of our model, we propose that cells view viral PB disassembly 339 as a danger signal and respond by increasing production of proinflammatory cytokines as a call 340 for reinforcements. 

All lentiviruses were generated using a second-generation system. Briefly, HEK293T cells were 383 transfected with pSPAX2, MD2G, and the plasmid containing a gene of interest using 384 polyethylimine (PEI, Polysciences). Viral supernatants were harvested 48 h post-transfection 385 and frozen at -80°C until use. For transduction, lentiviruses were thawed at 37°C and added to 386 target cells in complete media containing 5 µg/mL polybrene (Sigma) for 24 h. The media was 387 changed to selection media containing 1 µg/mL puromycin or 5 µg/mL blasticidin (Thermo 388

Fisher) and cells were selected for 48 hours before proceeding with experiments. 389

Cells were seeded onto coverslips for immunofluorescence experiments. Following treatment, 391 cells were fixed for 10 mins at 37 °C in 4% (v/v) paraformaldehyde (Electron Microscopy 392 Sciences). Samples were permeabilized with 0.1% (v/v) Triton X-100 (Sigma-Aldrich) for 10 393 min at room temperature and blocked in 1% human AB serum (Sigma-Aldrich) 1 h at room 394 temperature. Primary and secondary antibodies were diluted in 1% human AB serum and used at 395 the concentrations in Table 1 . Nuclei were stained with DAPI. Samples were mounted with 396

Prolong Gold AntiFade mounting media (Thermo). 397

Cells were lysed in 2X Laemmli buffer and stored at -20°C until use. The DC Protein Assay 399 (Bio-Rad) was used to quantify protein concentration as per the manufacturer's instructions. 10-400 15 µg of protein lysate was resolved by SDS-PAGE on 4-15% gradient TGX Stain-Free 401 acrylamide gels (BioRad). Total protein images were acquired from the PVDF membranes after 402 transfer on the ChemiDoc Touch Imaging system (BioRad). Membranes were blocked in 5% 403 BSA in TBS-T. Primary and secondary antibodies were diluted in 2.5% BSA, and used at the 404 dilutions found in Table 1 . Membranes were visualized using Clarity Western ECL substrate and 405

the ChemiDoc Touch Imaging system (BioRad). SsoFast EvaGreen Mastermix (Biorad) was used to amplify cDNA. The ∆∆quantitation cycle 418 (Cq) method was used to determine the fold change in expression of target transcripts. qPCR 419 primer sequences can be found in Table 2 420

Stocks of hCoV-OC43 (ATCC) were propagated in Vero E6 cells. To produce viral stocks, Vero 422 E6 cells were infected at an MOI of 0.01 for 1 h in serum-free DMEM at 33˚C. Following 423 infection, the viral inoculum was removed and replaced with DMEM supplemented with 2% 424 heat-inactivated FBS and 100 units/mL penicillin/streptomycin/glutamine. After 6 days, the 425 supernatant was harvested and centrifuged at 2000 RPM for 5 mins to remove cellular debris. 426

Virus stocks were aliquoted and stored at -80˚C for single use. Viral titers were enumerated 427 using Reed and Muench tissue-culture infectious dose 50% (TCID50) in Vero E6 cells (64). For 428 infection, cells were seeded onto coverslips to achieve ~70% confluency after 24 hours. The 429

following day, the growth media was removed and replaced with 100 µl of human CoV-OC43 430 inoculum and incubated at 37˚C for one hour, rocking the plate every 10 minutes to distribute 431 viral inoculum. Following incubation, the virus inoculum was removed and replaced with EGM-432

Processing bodies were quantified using an unbiased image analysis pipeline generated in the 436 freeware CellProfiler (cellprofiler.org) (91). First, detection of nuclei in the DAPI channel image 437 was performed by applying a binary threshold and executing primary object detection between 438 50 and 250 pixels. From each identified nuclear object, the "Propagation" function was 439 performed on the respective CoV2-ORF channel image to define cell borders. The identified cell 440 borders were masked with the identified nuclei to define a cytoplasm mask. The cytoplasm mask 441 was then applied to the processing body puncta channel image to ensure only cytoplasmic puncta 442 were quantified. Background staining was reduced in the cytoplasmic puncta channel using the 443 "Enhance Speckles" function. Using "global thresholding with robust background adjustments", 444 puncta within a defined size and intensity range were quantified. Size and intensity thresholds 445

were unchanged between experiments with identical staining parameters. Intensity measurements 446 of puncta and CoV2-ORF staining were quantified. Quantification data was exported and 447

RStudio was used for data analysis. with lentiviruses expressing either a GFP-control or GFP-Dcp1a prior to being infected with 502 OC43 (with a viral stock of 3.5x10 4 TCID50/mL). Samples were fixed at 6, 12, and 24 hpi (only 503 6 and 24 hpi shown) and stained for OC43-N protein (red) and nuclei (blue). Scale bar=20 μm. 504 B: Using images from A, infected and uninfected cells were quantified at 6, 12, and 24 hpi. 505

Values are represented as fold-change relative to the paired GFP control for each time point. For 506 6 hpi, n=2; for 12 and 24 hpi n=3. C: Supernatants were harvested at 24 hpi and titrated on naive 507

Vero E6 cells using TCID50. n=2. 508 509 Figure 6 : Processing bodies are a nexus point for virus-host conflict. In part one of our model, 510

we hypothesize that PBs are direct-acting antiviral granules that can restrict virus infection when 511 present as visible condensates; for this reason, they are targeted for disassembly by most viruses. 512

In part two of our model, we propose that viral PB disassembly is perceived by the cell as a 513 danger signal and relieves suppressed cytokine transcripts to produce proinflammatory cytokines 514 that recruit and activate immune cells. In this way, PB disassembly may also contribute to the 515 pathogenic cytokine responses that underly many viral illnesses including COVID. 516 517 Figure S1 : Hedls/Edc4 staining colocalizes with GFP-Dcp1a puncta to visualize processing 518 bodies. HeLa Flp-In TREx GFP-Dcp1a cells were induced with 1 μg/mL doxycycline for 24 h. 519

Samples were fixed and immunostained for the PB resident protein Hedls/Edc4 (red). Scale 520 bar=20 μm. 521 522 523 

The dual organization of P-bodies revealed by 537 immunoelectron microscopy and electron tomography

Purification Reveals the Condensation of Repressed mRNA Regulons

RNP Granule Formation: Lessons from P-Bodies and Stress 543

Mammalian stress granules and P bodies at 545 a glance

Biomolecular condensates 547 amplify mRNA decapping by coupling protein interactions with conformational changes 548 in Dcp1/Dcp2

Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated 551 Granules and Bodies

mRNP architecture in translating and stress conditions reveals an 553 ordered pathway of mRNP compaction

Transcriptome-Wide Comparison of Stress Granules and 555 P-Bodies Reveals that Translation Plays a Major Role in RNA Partitioning

ARED-Plus: an updated and expanded database of AU-558 rich element-containing mRNAs and pre-mRNAs

Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common 562 Functional Clusters Regulated by Key RNA-Binding Proteins

Transforming growth factor 565 β regulates P-body formation through induction of the mRNA decay factor tristetraprolin

Kaposi's sarcoma-associated herpesvirus G-protein-coupled receptor prevents AU-rich-569 element-mediated mRNA decay

Viral Activation of MK2-hsp27-p115RhoGEF-571

RhoA Signaling Axis Causes Cytoskeletal Rearrangements, P-body Disruption and ARE-572 mRNA Stabilization

TTP and BRF proteins nucleate processing body 575 formation to silence mRNAs with AU-rich elements

Dual RNA 578 Processing Roles of Pat1b via Cytoplasmic Lsm1-7 and Nuclear Lsm2-8 Complexes

Viral activation of stress-regulated Rho-GTPase signaling 581 pathway disrupts sites of mRNA degradation to influence cellular gene expression. Small 582 GTPases

Cytosolic Droplets for Coordinated mRNA Storage. Trends 584 Genet

Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory 587 cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel 588 disease

DDX6 (Rck/p54) is required for efficient hepatitis C virus 590 replication but not for internal ribosome entry site-directed translation

Spatio-temporal characterization of the antiviral 593 activity of the XRN1-DCP1/2 aggregation against cytoplasmic RNA viruses to prevent 594 cell death. Cell Death & Differentiation

Ostareck-Lederer A. DDX6 and its orthologs as 596 modulators of cellular and viral RNA expression

Multiple Poliovirus Proteins Repress Cytoplasmic 599 RNA Granules. Viruses. Multidisciplinary Digital Publishing Institute

Poliovirus-mediated disruption of cytoplasmic 602 processing bodies

Strategies 604 for Success. Viral Infections and Membraneless Organelles

Translation inhibition and stress granules in the antiviral 607 immune response

Cytoplasmic RNA Granules and Viral Infection

Critical role of 612 an antiviral stress granule containing RIG-I and PKR in viral detection and innate 613 immunity

Emerging roles for RNA degradation in viral replication and 615 antiviral defense

Helicase DDX6 Associates with RIG-I to Augment Induction of Antiviral Signaling

IRAV 620 (FLJ11286), an Interferon-Stimulated Gene with Antiviral Activity against Dengue Virus, 621 Interacts with MOV10

MOV10 interacts with Enterovirus 623 71 genomic 5'UTR and modulates viral replication

Antiviral Activity against RNA Viruses by Enhancing RIG-I-MAVS-Independent IFN 627 Induction

P body-629 associated protein Mov10 inhibits HIV-1 replication at multiple stages

Cellular 5"-3" mRNA exonuclease Xrn1 controls double-stranded 632 RNA accumulation and anti-viral responses. Cell Host and Microbe

LSm14A is a processing body-638 associated sensor of viral nucleic acids that initiates cellular antiviral response in the early 639 phase of viral infection

Coronavirus biology and replication: 641 implications for SARS-CoV-2

Origin and evolution of pathogenic coronaviruses

Interleukin-6 signaling drives fibrosis in unresolved inflammation

Imbalanced host response to SARS-CoV-2 drives 649 development of COVID-19

Clinical and immunological 651 features of severe and moderate coronavirus disease 2019

CoV-2: a storm is raging

The proximal origin of 656 SARS-CoV-2. Nature Medicine

SARS-CoV-2 Viral

Upper Respiratory Specimens of Infected Patients

Type I and Type III Interferons -Induction, Signaling, Evasion, and 661 Application to Combat COVID-19. Cell Host and Microbe

Auto-663 antibodies against type I IFNs in patients with life-threatening COVID-19

Inborn errors of 666 type I IFN immunity in patients with life-threatening COVID-19

Inflammation and Intussusceptive 669

Angiogenesis in COVID-19: everything in and out of Flow

SARS-CoV-2 nsp13, 672 nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerging Microbes & 673 Infections

CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon 676 signaling

CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory 679 epithelial derived cells and cardiomyocytes. bioRxiv

SARS-CoV-681 2 disrupts splicing, translation, and protein trafficking to suppress host defenses

SARS-CoV-2 ORF3b 684 Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring 685 Elongation Variant. CellReports

The 687 polypyrimidine tract-binding protein affects coronavirus RNA accumulation levels and 688 relocalizes viral RNAs to novel cytoplasmic domains different from replication-689 transcription sites

Mouse hepatitis 691 coronavirus replication induces host translational shutoff and mRNA decay, with 692 concomitant formation of stress granules and processing bodies

Dcp1a and GW182 Induce Distinct Cellular 695 Aggregates and Have Different Effects on microRNA Pathway

CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-699 Repurposing

Viral manipulation of a novel 701 mechanoresponsive signaling axis disassembles processing bodies

Assays for monitoring viral manipulation 704 of host ARE-mRNA turnover

The vascular endothelium: the cornerstone of 706 organ dysfunction in severe SARS-CoV-2 infection

Endothelial cell infection and endotheliitis in COVID-19

COVID-19 is, in the end, an endothelial disease

Severe COVID-19 is a Microvascular Disease

Determination of 50% endpoint titer using a simple formula

Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a 718

Crucial Role in Coronaviral Life Cycle. Dutch RE, editor

Nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the 722 membrane-associated M protein. bioRxiv

A proposed role for the SARS-CoV-2 nucleocapsid protein in 724 the formation and regulation of biomolecular condensates. FASEB j

The coronavirus nucleocapsid is a multifunctional 727 protein. Viruses. Multidisciplinary Digital Publishing Institute

Phosphorylation of the arginine/serine dipeptide-rich 730 motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein 731 modulates its multimerization

Genomic 734 determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses

The 737 coronavirus nucleocapsid protein is dynamically associated with the replication-738 transcription complexes

Coronavirus RNA 740 Proofreading: Molecular Basis and Therapeutic Targeting

Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune 744 Response. Perlman S, editor

Genes with 5′ terminal 746 oligopyrimidine tracts preferentially escape global suppression of translation by the 747 SARS-CoV-2 NSP1 protein

CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

Regulation of Stress Responses and Translational Control by 752 Coronavirus

A common strategy for host RNA 754 degradation by divergent viruses

Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, 757 including that of type I interferon, in infected cells

Selective 759 Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host 760 Shutoff Protein

Severe Acute Respiratory 762

Syndrome Coronavirus Gene 7 Products Contribute to Virus-Induced Apoptosis

mRNA decapping enzyme 1a (Dcp1a)-induced 768 translational arrest through protein kinase R (PKR) activation requires the N-terminal 769 enabled vasodilator-stimulated protein homology 1 (EVH1) domain

P bodies: at the crossroads of post-772 transcriptional pathways

P-body 775 assembly requires DDX6 repression complexes rather than decay or Ataxin2/2L 776 complexes

K63-779 Ubiquitylation and TRAF6 Pathways Regulate Mammalian P-Body Formation and 780 mRNA Decapping

Decapping and decay of messenger RNA occur in cytoplasmic 782 processing bodies

c-Jun N-terminal kinase phosphorylates DCP1a to control formation of P 786 bodies

ARE-mRNA degradation requires the 5"-3" decay 788 pathway

CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-791 Repurposing

KSHV activates unfolded protein response 793 sensors but suppresses downstream transcriptional responses to support lytic replication

Improved 796 structure, function and compatibility for CellProfiler: modular high-throughput image 797 analysis software